The course will provide a broad overview of key topics in biostatistics that are frequently at the forefront of litigation involving drugs and medical devices. The course will include a review of basic concepts including relative risks, odds ratios, statistical significance and power, comparing proportions, survival analysis, Bayesian analysis, metanalysis, and common issues in trial clinical conduct. The course will also touch on how these concepts figure into judicial opinions. Participants will learn to identify common red flags and pit falls in statistical analysis, develop tools to more effectively conduct discovery and interface with experts, and develop a sense for how courts view and understand these issues.
Whether the Federal Government or individual State Governments, fraud enforcement, especially in hea...
MODERATED - Session 2 of 10 - Mr. Kornblum, a highly experienced trial and litigation lawyer for ove...
MODERATED-Part 1 of 2 - In this presentation, I will discuss strategies for cross-examining expert w...
The always idiosyncratic Nassim Taleb likes to say, “Nothing is more permanent than ‘tem...
Synthetic identity fraud creates a significant legal and compliance challenge for professionals by c...
Generative AI is transforming how lawyers work, but it’s also raising new ethical and practica...
For decades, the Rule of Two in government contracting required federal agencies to set aside contra...
The statistics are compelling and clearly indicate that 1 out of 3 attorneys will likely have a need...
MODERATED-Attorneys may offer a crucial role in discussing advance (end of life) care planning optio...
Explore the transformative potential of generative AI in modern litigation. “Generative AI for...